Why the study?
Does C-reactive protein velocity predict microvascular infarct pathology in patients with STEMI treated with primary PCI?
Does C-reactive protein velocity predict microvascular infarct pathology in patients with STEMI treated with primary PCI?
C-reactive protein velocity provides incremental predictive value over cTnT for identifying microvascular infarct pathology in STEMI patients treated with primary PCI.
May support CRPv for microvascular risk stratification in STEMI; hypothesis-generating and requires prospective validation before practice change.
In patients with STEMI treated with primary PCI, CRPv was associated with microvascular infarct pathology with a predictive value incremental to cTnT, suggesting CRPv as an early and sensitive biomarker for more severe infarct pathology and outcome.
No takes yet. Share an insight, caveat, or question.
Holzknecht et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: